Epidemiology and Pharmacoeconomic Issues Relating to Acute Respiratory Tract Infections and Acute Uncomplicated Infections of the Urinary Tract Neil M. H. Graham OriginalPaper 25 November 2012 Pages: 1 - 10
Defining Criteria for the Pharmacoeconomic Evaluation of New Oral Cephalosporins Peter G. DaveyM. Malek OriginalPaper 25 November 2012 Pages: 11 - 19
Cost-Effectiveness and Value of an IV Switch Peter Jewesson OriginalPaper 25 November 2012 Pages: 20 - 26
Third Generation Cephalosporins in the Parenteral to Oral Switch Diana Rimmer OriginalPaper 25 November 2012 Pages: 27 - 33
Choosing between the New Cephalosporin Antibiotics David P. NicolauRichard Quintiliani OriginalPaper 25 November 2012 Pages: 34 - 39
Cost-Effectiveness Opportunities for New Antibiotics Alan Hillman OriginalPaper 25 November 2012 Pages: 40 - 43